Stroke with transfusions changing to hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload
Pediatric Blood & Cancer2011Vol. 57(6), pp. 1011–1017
Citations Over TimeTop 10% of 2011 papers
Russell E. Ware, William H. Schultz, Nancy A. Yovetich, Nicole A. Mortier, Ofelia Álvarez, Lee Hilliard, Rathi V. Iyer, Scott T. Miller, Zora R. Rogers, John P. Scott, Myron A. Waclawiw, Ronald W. Helms
Abstract
Investigation of alternative treatments in SWiTCH could lead to changes in the management of cerebrovascular disease for selected patients with SCA, stroke, and iron overload.
Related Papers
- → A survey of phlebotomy among persons with hemochromatosis(1999)53 cited
- → Reducing the number of clinical stat phlebotomy orders: feasible or not?(2012)6 cited
- → Optimal Phlebotomy Interval to Change Hematocrit Levels in Patients with Polycythemia(2016)3 cited
- The Complete Textbook of Phlebotomy(1994)
- → Phlebotomy in a Community Teaching Hospital(1989)1 cited